Back to News
May 4, 2026 4:11 PM

Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12

– Company to Host Conference Call on May 12, 2026, at 4:30 p.m. ET,

SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that it will release its financial results for the first quarter ended March 31, 2026, after the market close on Tuesday, May 12, 2026. Management will host a conference call and webcast at 4:30 p.m. ET that same day.

Title:

Capricor Therapeutics First Quarter 2026 Financial Results and Recent Corporate Update Conference Call and Webcast

Date:

Tuesday, May 12, 2026

Time:

4:30 p.m. ET

Call Details:

Toll-Free: 1-800-717-1738International: 1-646-307-1865Conference ID: 60968Participants may dial in using the numbers above and ask to be joined to the call, or use the Call Me™ link for instant telephone access to the event.

Webcast: